Attending this event?
Back To Schedule
Monday, June 20 • 3:20pm - 3:50pm
#130 IT: Deloitte Innovation Theater: Sanofi’s Approach to Automating Adverse Event Case Processing Through Machine Learning and Innovation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

With the mission of protecting and improving human health and safety of medicines, life sciences organizations primarily drive to three objectives: Scientific innovation to discover & develop medicinal therapies; Deliver and sell therapies to healthcare professionals and patients; Continuously monitor safety and efficacy of therapies to protect patients. To ensure patient safety, life science organizations conduct continuous monitoring of the safety of their products by collecting, assessing and reporting Adverse Events (AE) from various sources a time-sensitive manner. Pharmacovigilance Organizations considers this a core/foundational activity to protect patients safety with over hundreds of thousands of AE cases annually. Processing of AE cases is an intensive, manual, expensive, and time-consuming activity and the entire process is highly regulated by global health authorities. In this presentation, learn how PV Organizations have demonstrated success and realized significant operational and scientific benefits through combining business and technology transformation leveraging natural language processing, machine learning and artificial intelligence with Deloitte’s ConvergeHEALTH Safety Cognitive Case Processing Platform.

In this presentation you will hear:
  • Strategies for bringing AI to reality in a highly regulated environment
  • Actual benefits and improvements in quality and efficiency that were achieved by real clients
  • Methodologies for measuring benefits and costs in the automation journey
  • Mitigation strategies for potential roadblocks, such as GxP validation expectations, quality management system adjustments, and vendor/outsourcing cooperation
  • Lessons learned from our clients’ journey from proof-of-concept to production roll out
  • Change management, communication and negotiation strategies required to achieve benefits both with internal and external stakeholders

  • Chair



    Sapna Elzer

    Amanda Bowles, MS

    Glenn Carroll, MBA

    avatar for Amanda Kirby Bowles

    Amanda Kirby Bowles

    Managing Director, Deloitte, United States
    Amanda has over 13 years of life sciences experience including over 10 years specializing as a pharmacovigilance and drug safety systems subject matter advisor. Amanda has in depth experience in drug safety, pharmacovigilance and regulatory affairs, including extensive experience... Read More →
    avatar for Glenn Carroll

    Glenn Carroll

    Principal, Deloitte, United States
    Glenn Carroll is a principal in our life science strategy practice with over 15 years pharmaceutical and biotech experience. Glenn leads Deloitte's US Safety and Medical practices. He has a strong track record in delivering strategic and operational excellence, specifically in the... Read More →
    avatar for Deloitte


    United States

    Sapna Elzer

    PV Data Strategy Lead, Sanofi, United States

    Monday June 20, 2022 3:20pm - 3:50pm CDT
    Exhibit Hall Theater #2 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616